HDAC6 and neoplasm: Notably, ACY-1215 (ricolinostat), a well-known HDAC6 inhibitor, has shown efficacy inducing cell proliferation inhibition, apoptosis, and G1 cell cycle arrest, exhibiting significant anti-tumor effects in TNBC cells [27].